Recently, provinces and municipalities around the new crown nucleic acid rapid test program costs have been adjusted in relation to the new crown. Whether it is a single person single test, or multiple mixed test, the price of the new crown nucleic acid rapid test has been adjusted downward to some extent.
In the case of price adjustment, many people have questions, since the price of the new crown nucleic acid rapid test can be adjusted downward, then why not regulate the price at the beginning?
From the initial 120 yuan / time to the current general 5-60 yuan / time, the new crown nucleic acid rapid test intermediate profit is too high?
There are even comments that the new crown nucleic acid rapid test is just a sample, how to charge so high?
New Coronavirus is a new type of virus that was first discovered in late 2019. When it was first discovered, the SARS virus kit was used for the rapid new coronavirus nucleic acid test. It was thought that the New Coronavirus was the SARS virus, but after a series of nucleic acid sequence tests was proven to be a novel virus. The major manufacturers in the diagnostic industry began to invest funds and manpower in the research and development of the new crown nucleic acid rapid test kit. Under the circumstances that the initial research and development was not completed and the new crown nucleic acid rapid test kit was lacking, the cost of conducting a new crown nucleic acid rapid test was naturally relatively high about 120 yuan/time.
Then a gene company in Guangzhou became one of the first manufacturers in China to develop and pass the approval of the State Drug Administration for the new crown nucleic acid rapid test reagents. With the successful development and production of manufacturers, the number of new crown nucleic acid rapid test reagents increased, and the cost of new crown nucleic acid rapid nucleic acid test began to drop to about 80 yuan per test. Later, with the improvement of New Crown Nucleic Acid Rapid Test reagent R&D technology and the increase of reagent production, the cost of New Crown Nucleic Acid Rapid Test dropped again. Now, in the post-epidemic era, as the epidemic situation has become normalized, the Nucleic Acid Rapid Test will also be normalized and has been included in the medical insurance reimbursement in some areas, which has allowed the cost of the Nucleic Acid Rapid Test to be adjusted downward once again under national control.
Is it really as simple as taking a sample for the New Crown Nucleic Acid Rapid Test?
No, there are many steps that need to be taken in the process of rapid nucleic acid testing, and sampling is only one of these steps. Before sampling, manufacturers need to produce sample preservation solution, after sampling, reagent preparation, sample pretreatment, nucleic acid extraction, nucleic acid amplification and analysis of several steps to produce the results of the new crown nucleic acid rapid test.
There are four areas in the laboratory for the New Crown Nucleic Acid Rapid Test, namely the reagent preparation area, sample preparation area, amplification area and product analysis area.
In the reagent preparation area, the laboratory staff receives the samples collected by the sampler, and then prepares, dispenses, and stores the required amplification reagents.
In the sample preparation area, experimenters are responsible for sample information registration, dispensing, nucleic acid extraction, preservation and spiking of samples.
Amplification area and product analysis area: the two areas are strictly separated and different rooms must be used, with a certain interval between the two areas. The amplification zone is mainly for amplifying replicate nucleic acid samples; the product analysis zone is to analyze whether the nucleic acid in the sample can detect the specific viral nucleic acid sequence paired with the standard sample, and if it can be detected by the new crown nucleic acid rapid test instrument, it will be judged as positive, if not detected, it will be negative, and then registered and reported.
